Literature DB >> 14586139

Pharmacology of ifosfamide.

M Furlanut1, L Franceschi.   

Abstract

Ifosfamide is a bifunctional alkylating agent, used as a racemic mixture by intravenous route in the treatment of various tumors. It is an oxazaphosphorine derivative with a structural formula similar to that of cyclophosphamide. As a prodrug it requires activation in the liver by a cytochrome mixed-function oxidase system. Among various metabolites, ifosforamide mustard probably represents the most important cytotoxic compound able to produce irreparable cross-links between DNA strands. Resistance is due to the ability of neoplastic cells to repair DNA damages. Acrolein may induce hemorrhagic cystitis, whereas chloroacetaldehyde may be responsible both for nephro- and neurotoxicity. A thiol donor (mesna) can prevent urotoxic effects but not nephro- and neurotoxicity. Pharmacokinetics is markedly influenced by route of administration and duration of treatment, age, co-medication, liver and renal function. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586139     DOI: 10.1159/000073350

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  22 in total

1.  Ifosfamide induced Fanconi syndrome.

Authors:  Samantha Buttemer; Mohan Pai; Keith K Lau
Journal:  BMJ Case Rep       Date:  2011-12-20

2.  Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.

Authors:  Gerald Schwerdt; Antje Kirchhoff; Ruth Freudinger; Brigitte Wollny; Andreas Benesic; Michael Gekle
Journal:  Pediatr Nephrol       Date:  2007-02-02       Impact factor: 3.714

3.  Towards personalized medicine with a three-dimensional micro-scale perfusion-based two-chamber tissue model system.

Authors:  Liang Ma; Jeremy Barker; Changchun Zhou; Wei Li; Jing Zhang; Biaoyang Lin; Gregory Foltz; Jenni Küblbeck; Paavo Honkakoski
Journal:  Biomaterials       Date:  2012-03-18       Impact factor: 12.479

4.  Screening for Biologically Annotated Drugs That Trigger Triacylglycerol Accumulation in the Diatom Phaeodactylum.

Authors:  Melissa Conte; Josselin Lupette; Khawla Seddiki; Coline Meï; Lina-Juana Dolch; Valérie Gros; Caroline Barette; Fabrice Rébeillé; Juliette Jouhet; Eric Maréchal
Journal:  Plant Physiol       Date:  2018-03-13       Impact factor: 8.340

5.  Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells.

Authors:  Gerald Schwerdt; Nader Gordjani; Andreas Benesic; Ruth Freudinger; Brigitte Wollny; Antje Kirchhoff; Michael Gekle
Journal:  Pediatr Nephrol       Date:  2005-11-03       Impact factor: 3.714

6.  Ifosfamide toxicity in cultured proximal renal tubule cells.

Authors:  James Springate; Mary Taub
Journal:  Pediatr Nephrol       Date:  2006-10-27       Impact factor: 3.714

Review 7.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

8.  Severe ifosfamide-induced neurotoxicity: a case report.

Authors:  Sara Ramos Linares; Joaquín Breña Atienza; Matilde Cháfer Rudilla; Pablo Ríos Rull; Ana Cabello Rodríguez; Javier Merino Alonso
Journal:  Pharm World Sci       Date:  2009-12-23

9.  The Effect of Acetylcysteine on Renal Function in Experimental Models of Cyclophosphamide-and Ifosfamide-Induced Cystitis.

Authors:  Lukasz Dobrek; Klaudia Nalik-Iwaniak; Kinga Fic; Zbigniew Arent
Journal:  Curr Urol       Date:  2020-10-13

10.  Ifosfamide may be safely used in patients with end stage renal disease on hemodialysis.

Authors:  Sheron Latcha; Robert G Maki; Gary K Schwartz; Carlos D Flombaum
Journal:  Sarcoma       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.